Market Turnover
-






-
-
|
|
|
|
|
|
-
-
-
Loading

Exchange’s Disciplinary Action against a Former Director of China Tian Yuan Healthcare Group Limited (Stock Code: 557)

Regulatory
26 Oct 2023

香港聯合交易所有限公司
(香港交易及結算所有限公司全資附屬公司)
THE STOCK EXCHANGE OF HONG KONG LIMITED
(A wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited)

 

The Stock Exchange of Hong Kong Limited 

IMPOSES A DIRECTOR UNSUITABILITY STATEMENT against:

Ms Zhang Xian, former chief executive officer and executive director of China Tian Yuan Healthcare Group Limited (stock code: 557).

The statement made in respect of Ms Zhang above is made in addition to a public censure against her. The Director Unsuitability Statement is a statement that, in the Exchange’s opinion, Ms Zhang is unsuitable to occupy a position as director or within senior management of the Company or any of its subsidiaries.

 

The Listing Division conducted an investigation into Ms Zhang’s discharge of directors’ duties and obligations under the Listing Rules. Ms Zhang did not respond to the Division’s investigation and reminder letters. She failed to cooperate in the investigation.

Key messages:

Failure to cooperate in the Exchange’s investigation is a serious breach of the Listing Rules.

A director’s obligation to cooperate does not lapse after his or her resignation. 
 
A copy of the Statement of Disciplinary Action can be found on the HKEX website.

 

 

Ends